Study of Erythropoietin and number of antibiotics in renal failure and thalassemia patients
Article Sidebar
Main Article Content
Abstract
The current study included 130 people over a period of research from October 2015 to May 2016 who have renal failure and thalassemia. Samples were studied divided in three groups: the first group: included 50 people (62-20 years) with renal failure, and the second group: included 50 people(30-12 years) infected with thalassemia in addition to the 30 people (18-54 years) represented a group of healthy control. The present study aimed to find out the dynamic effect of the hormone erythropoietin and its role in anemia by examining the level of serum hormone erythropoietin among patients with thalassemia as well as anemia in patients with renal failure, in addition to the effect of some of the biochemical parameters associated antioxidants system such as Glutathione (GSH), superoxide dismutase (SOD) and catalase. The study concludes the following results: The results showed a significant decrease (P≤0.01) in the concentration of the erythropoietin hormone in the two groups of patients renal failure while there was a significant increase in patients with a group of thalassemia for males and did not record results significant difference for a group of female thalassemia patients when compared with the control group. The results show that there is a significant decrease in the level of glutathione and SOD and catalase enzyme, and for both males and females in the patients groups when compared with the control group
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Mollaoğlu, M. (2015). Anemia and Coagulation
Disorders in Dialysis Patient. In: Gökdoğan, F., Ed.,
Dialysis Principles and Techniques; Ankara,
Akademisyen Tıp Kitabevi. 237-244.
2- Moore, E. and Bellomo, R. (2011). Erythropoietin
(EPO) in acute kidney injury; Ann Intensive Care. 1:
3.
3- Bahlmann, F. and Fliser, D.(2009). Erythropoietin
and renoprotection; Curr. Opin. Nephrol. Hypertens.
18. 15–20.
4- Koca, T.; Berber, A.; Koca, H.; Demir, T. and
Koken, T. (2010 ) . Effects of hemodialysis period
on levels of blood trace elements and oxidative stress;
Clin. Exp. Nephrol. 14 463–468.
5- Khalil, S.; Amer, H.; El Behairy, A. and Warda,
M. (2016). Oxidative stress during erythropoietin
hyporesponsiveness anemia at end stage renal
disease: Molecular and biochemical studies; Journal
of Advanced Research .7. 348–358.
6- Fassett, R. Ball, M.J. and Robertson, I. (2009).
The Lipid lowering and Onset of Renal Disease
(LORD) Trial: a randomized double blind placebo
controlled trial assessing the effect of atorvastatin on
the progression of kidney disease; BMC Nephrol. 9 :
4–9.
7- AL-Zamely, O.; AL-Nimer, M. and Muslih R.
(2001). "Detection the level of peroxynitrate and
Related with antioxidant status in the serum of
patients with acute myocardial infection"; Nat. J.
Chem., 3:625-637.
8- Steel, R. and Torries, J. (1980). Principle and
Procedures of Statistics: A Biochemical Approach;
2nd edition, McGraw-Hill Book Company Inc., New
York, USA.
9- Rahman, M.; Krull, S.; Rahman, S.; Kanda, M.;
Narita,; S. Bilano, V. and Ota E. (2016). Stuart
Gilmour3, and Kenji Shibuya3Maternal anemia and
risk of adverse birth and health outcomes in low- and
middle-income countries: systematic review and
meta-analysis; Am. J. Clin. Nutr. 104( 5):135-143 .
10- Besarab, A.; Amin, N.; Ahsan, M.; Vogels, E.;
Zaznwa, G.; Frinak, S.; Zazra, J. and Anandan, J.
(2000). Optimization of epoetin therapy with
intravenous iron therapy in hemodialysis patients ; J.
Am. Soc. Nephrol. 11:530 – 538.
11- Scanlon, V. and Sanders, T. (2007). Essentials of
anatomy and physiology; F.A. Davis company
Philadelphia .18: 228.
12- Menon, M.; Karur, V.; Bogachera, O.; Cuetara, B.
and Woj, C. (2006). Signals for stress erythropoiesis
receptor – phosphoty – rosin–343– stat 5 axis; J. Clin.
Invest; 116: 683–694.
13- Haperin, M.; Cheema – Dhadli, S. and Kamel, S.
(2006). Properties permitting the renal cortex to be
the oxygen sensor for relase of erythropoietin:
Clinical Implication; Clin. J. Am. Soc. Nephrol. 1:
1049 – 1053.
14- Vlahakos, D.; Marathias, K.; Agrrogannis, B. and
Madias, N. (2004). Posttransplant erythrocytosis;
Kidney Int .63: 1187 – 1194.
15- Protoles, J.; Lopez–Gomz, J. and Aligama, P.
(2006). Anemia management and treatment response
in patients on hemodialysis: The MAR study; J.
Nephrol., 19 :352 – 360.
16- Bamgbola, O. and Resistanc, T. (2010).
Erythropoietin - stimulating agents: etiology,
evaluation and therapeutic considerations; Pediatr.
Nephrol. 27(2):195–205.
17- Marsden, J. (2006). Erythropoietin mesurment
and dinical application; Ann. Clin. Biochem . 43: 97
– 104.
18- Fesler, P.; Du Cailar, G.; Ribstein, J. and Mimran,
A. (2003). Ventricular remodeling and renal function
in never – treated essential hypertiention ; J. Am. Soc.
Nephrol. 14: 88 – 887.
19- Çetin, M.; Ünal, Ş.; Gümrük, F.; Gürgey, A. and
Altay, Ç. (2009). Serum Erythropoietin Levels in
Pediatric Hematologic Disorders and Impact of
Recombinant Human Erythropoietin Use; Turk. J.
Hematol. 26:72-6 .
20- Locatelli, F.; Pisoni, R. and Combe, C. (2004).
Anaemia in haemodialysis patients of five European
countries: association with morbidity and mortality in
the Dialysis Outcomes and Practice Patterns Study
(DOPPS); Nephrol. Dial. Transplant.19:121–32.
21- Gonzalez Rico, M.; Puchades, M.; Garcia Ramon,
R.; Saez, G.; Tormos, M. and Miguel, A. (2006) .
Effect of hemodialysis therapy on oxidative stress in
patients with chronic renal failure; Nefrologia. 26:
218–25 .
22- Khan, M.; Siddiqui, S.; Parveen, K.; Javed, S.;
Diwakar, S. and Siddiqui, W. (2010).
Nephroprotective action of tocotrienol-rich fraction
(TRF) from palm oil against potassium dichromate
(K2Cr2O7)-induced acute renal injury in rats; Chem.
Biol. Interact .186:228– 238.
23- Ghara, A.; Ghadi, F. and Dhawan, D. (2014).
Evaluation role of Neem Leaf Extract on Mitotic
Catastrophe in DMH-induced Colon Carcinogenesis
in rats ; Adv. Biores., 74 : 84-91.
24- Poulianiti, K.; Kaltsatou, A.; Mitrou, G.;
Jamurtas, A.; Koutedakis, Y.; Maridaki, M.;
Stefanidis, I.; Sakkas, G. and Karatzaferi, C. (2016).
Systemic Redox Imbalance in Chronic Kidney
Disease: A Systematic Review; Oxidative Medicine
and Cellular Longevity: 19.
25- Pavlova, L.; Savov, V.; Petkov, H. and Charova,
I. (2007). Oxidative stress in patient with β-
thalassemia major; Contributions, Sec. Biol. Med.
Sci. 3:145–154.
26- Akram, K.; Tahereh, T.; Fatemeh, R. and Arash,
A. (2010). The Relationship between The Antioxidant
Intake and Blood Indices of The Children With
Thalassemia In Sabzever And Mashhad; Pakistan J.
of Nutrition; 9( 7) :716–719.
27- Kuldeep, K.; Amit, M. and Archana, T. (2011).
Production of reactive oxygen species, its effects,
drugs and plant extract used as an antioxidant,
chelator on thalassemic patients: A Review;
International J. of Pharma Sciences and Research. 2
(9):2278-2285.
28- Ruchaneekorn, W.; Noppadol, S.; Praphaipit, I.
Ratiya, C. Narumol, P. Suneerat, H. Somdet, S.
Chada, P. Eliezer, R. and Suthat, F. (2010).
Improvement in oxidative stress and antioxidant
parameters in ß-thalassemia/ Hb E patients treated
with curcuminoids; Clinical Biochemistry. 43:424–
429.
29- Attia, A.; Sayed, A.; Ibrahim, F.; Mohammed, A.
and El-Alfy, M. (2011). Effects of antioxidant
vitamins on some hemoglobin properties and
erythrocytes in homozygous beta-thalassemia;
Romanian J. Biophys.21:1–16.
30- Tolba, M.; Soliman, N.; El- kamah, G. and ELshehaby,
A. (2015). Oxidative Stress Parameters in
Beta-Thalassemia; International Journal of Life
Sciences Research . 3(4): 1-7.